Alexandra Noël

Associate Professor and Director of Inhalation Laboratory Louisiana State University

  • Baton Rouge LA

Dr. Noël's research focuses on the production and characterization of aerosols, as well as inhalation and developmental toxicology.

Contact

Louisiana State University

View more experts managed by Louisiana State University

Media

Biography

Alexandra Noël received her bachelor’s degree in biomedical sciences, her master’s in occupational and environmental health, as well as her PhD in Public Health, with a specialization in Toxicology and Risk Assessment, all from the Faculty of Medicine of the University of Montreal (Quebec, Canada). She is an Associate Professor in the Department of Comparative Biomedical Sciences at Louisiana State University (LSU) and the Director of the LSU Inhalation Research Facility. She conducts in vitro and in vivo inhalation toxicology studies on cardio-pulmonary effects resulting from in utero and adult exposures to second-hand smoke, electronic-cigarette aerosols, nanoparticles, and particles from air pollution. Her publication record includes 48 peer-reviewed scientific articles. In addition, Dr. Noël is the leader of the Inhalation Toxicology Core of the LSU Superfund Research Program and the Director of Inhalation & Infection Core of the LSU Lung COBRE. She is a counselor for the Inhalation and Respiratory Specialty Section (IRSS) (2024-2026) of the Society of Toxicology (SOT). She is also the Chair of the Membership Committee (2025-2026) of the American Thoracic Society (ATS). Dr. Noël is also a member of the National Institutes of Health (NIH) Advisory Committee on Research on Women’s Health (2022-2026) and she is an Associate Editor for the American Journal of Respiratory Cell and Molecular Biology. Dr. Noël’s laboratory is currently funded by the NIGMS, the NIEHS and the NHLBI.

Areas of Expertise

Inhalation Toxicology
Developmental Toxicology
Vaping Research
Tobacco Products
Pulmonary Diseases
Molecular Biology
Aerosols

Research Focus

Prenatal Vaping Exposure & Respiratory Toxicology

Dr. Noël’s research focuses on how prenatal exposure to vaping aerosols, engineered nanoparticles, and other airborne pollutants programs neonatal lungs for diseases such as allergic asthma. She pairs custom aerosol generation with inhalation toxicology, in-utero disease models, and epigenetic profiling to uncover pathways linking early exposure to lifelong respiratory risk.

Accomplishments

Award—Distinguished Scholar Award, Louisiana State University School of Veterinary Medicine

2025

Dean’s Teacher Merit Honor Award, Louisiana State University School of Veterinary Medicine

2025

Award—Young Investigator Award, SOT Inhalation and Respiratory Specialty Section (IRSS)

2024

Show All +

Education

Université de Montréal

Ph.D.

2013

Université de Montréal

M.Sc.

2007

Université de Montréal

B.S.

2003

Affiliations

  • Society of Toxicology (SOT)
  • American Thoracic Society (ATS)

Media Appearances

LSU researcher leads major study on effects of vaping

WAFB 9  tv

2020-03-03

“It’s only the tip of the iceberg. Doctors are just now seeing the harmful effects,” said Dr. Noël, assistant professor of comparative biomedical sciences at the LSU School of Veterinary Medicine. “It’s mostly young people and mostly men.”

View More

LSU researcher pursues research into harmful effects of e-cigarette use, receives FDA funding

LSU Reveille  online

2020-03-01

Alexandra Noël, a School of Veterinary Medicine assistant professor of comparative biomedical sciences, will engage in a multi-year research project funded by the FDA and National Institutes of Health to study the short- and long-term effects of e-cigarette use on the lungs.

“These deaths and illnesses are related to vaping, and it’s only the tip of the iceberg,” Noël said. “Doctors are just now seeing the harmful effects.”

View More

Local LSU researcher helms FDA sponsored study into effects of vaping

WRBZ 2  online

2020-02-04

Dr. Alexandra Noël, an assistant professor of Comparative Biomedical Sciences at the LSU School of Veterinary Medicine, says, "People initially thought vaping was safer than cigarette smoking. We could see in the lab that it is not safe. Inhaling e-cigarette vapor is harmful."

View More

Show All +

Articles

MMP12 deficiency attenuates menthol e-cigarette plus house dust-mite effects on pulmonary iron homeostasis and oxidative stress

Respiratory Research

2025

Little is known regarding the pulmonary effects induced by the inhalation of menthol-flavored e-cigarette aerosols on asthma exacerbation, despite the popularity of these devices and flavors among youth and young adults. In the lungs, matrix metalloproteinase 12 (MMP12) expressed and secreted by both alveolar macrophages and bronchial epithelial cells plays an essential role in airway remodeling, a key feature of severe asthma. In this study, we investigated the role of MMP12 in menthol-flavored e-cigarette aerosol exposures plus house-dust mite (HDM)-induced asthmatic responses.

View more

AhR Activation at the Air-Blood Barrier Alters Systemic microRNA Release After Inhalation of Particulate Matter Containing Environmentally Persistent Free Radicals

Cardiovascular Toxicology

2025

Particulate matter containing environmentally persistent free radicals (EPFRs) is formed when organic pollutants are incompletely burned and adsorb to the surface of particles containing redox-active metals. Our prior studies showed that in mice, EPFR inhalation impaired vascular relaxation in a dose- and endothelium-dependent manner. We also observed that activation of the aryl hydrocarbon receptor (AhR) in the alveolar type-II (AT-II) cells that form the air-blood interface stimulates the release of systemic factors that promote endothelial dysfunction in vessels peripheral to the lung. AhR is a recognized regulator of microRNA (miRNA) biogenesis, and miRNA control diverse signaling pathways.

View more

Precision Cut Lung Slices: Emerging Tools for Preclinical and Translational Lung Research. An Official American Thoracic Society Workshop Report

American Journal of Respiratory Cell and Molecular Biology

2024

The urgent need for effective treatments for acute and chronic lung diseases underscores the significance of developing innovative preclinical human research tools. The 2023 ATS Workshop on Precision Cut Lung Slices (PCLS) brought together 35 experts to discuss and address the role of human tissue-derived PCLS as a unique tool for target and drug discovery and validation in pulmonary medicine. With increasing interest and usage, along with advancements in methods and technology, there is a growing need for consensus on PCLS methodology and readouts. The current document recommends standard reporting criteria and emphasizes the requirement for careful collection and integration of clinical metadata. We further discuss current clinically relevant readouts that can be applied to PCLS and highlight recent developments and future steps for implementing novel technologies for PCLS modeling and analysis. The collection and correlation of clinical metadata and multiomic analysis will further advent the integration of this preclinical platform into patient endotyping and the development of tailored therapies for lung disease patients.

View more

Show All +

Research Grants

Impact of prenatal exposures to copper from electronic nicotine delivery system (ENDS) aerosols on the immature neonatal pulmonary immune system and IL-10-mediated asthmatic responses

NIH NHLBI 1R01HL176980

2025-2030

Leveraging social-behavior factors of pregnant women in Louisiana and in vivo models to study the impact of maternal vaping on birth outcomes and asthma in offspring

Our Lady of the Lake Health and Louisiana State University Collaboration In Action Program

2025-2026

ENDS aerosol particle deposition, in utero exposures and children's respiratory health effects (ENDURE) Consortium

NIH NIEHS 1R01ES035694-01 (ViCTER grant)

2025-2028

Show All +

Social